Innoviva (INVA) Stock Insights

INVA price $21.12 +0.18 +0.86%

Ticker
INVA
Price
$21.12
Change
+0.18 +0.86%
Market cap ?
$1.53B
P/E ?
4.29
Forward P/E ?
8.73
Dividend yield ?
0.00%
Beta ?
0.33
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
70
Value
72
Quality
71
Growth
67

Stocklytics score rationale: value 72, quality 71, growth 67.

Financials

2016201720182019202020212022202320242025
133569000217217000261004000261016000336794000391866000331339000310463000358711000425128000

Innoviva, Inc. functions as a pharmaceutical company, concentrating on the worldwide creation and marketing of medical treatments. Its current product lineup prominently includes several once-daily combination therapies: RELVAR/BREO ELLIPTA, which integrates vilanterol (a long-acting beta2 agonist, or LABA) with fluticasone furoate (an inhaled corticosteroid, or ICS); ANORO ELLIPTA, a medication that pairs…

Fair value

INVA fair value $29.79. Price $21.12. Price is 29% below fair value.

Below fair value, but more expensive than usual. A smaller discount than on 80% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 188.32M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 72.25M. Net debt -281.92M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare INVA

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—0.52—115.31M
2026-08-051.140.44119.59M110.98M
2026-05-060.440.4397.99M101.57M
2026-02-251.940.34114.61M102.62M
2025-11-051.080.46107.80M91.36M
2025-08-060.770.57100.28M92.04M
2025-05-070.740.2988.63M82.67M
2025-02-260.260.3491.81M86.80M
2024-11-060.020.2789.51M76.91M
2024-07-31-0.550.2499.90M74.69M
2024-05-080.460.1777.50M68.00M
2024-03-010.760.2385.84M75.52M
2023-11-010.980.2767.26M75.66M
2023-08-020.020.2680.99M67.92M
2023-04-260.420.2376.37M62.01M
2023-02-280.250.4165.80M58.85M
2022-11-092.802.7567.26M62.60M
2022-07-270.051.47108.22M214.78M
2022-04-270.350.4490.06M86.40M
2022-02-090.550.41107.68M106.37M
2021-10-270.900.4397.86M76.04M
2021-07-280.900.29100.81M111.23M
2021-04-280.84-0.0185.52M—
2021-02-030.480.4090.48M74.50M
2020-10-280.280.4288.69M143.27M
2020-07-290.690.3278.95M68.69M
2020-04-290.590.3678.68M70.32M
2020-02-050.420.5075.97M90.44M
2019-10-300.360.3765.75M67.58M
2019-07-240.340.4364.11M81.08M
2019-05-010.310.3655.18M64.08M
2019-02-062.340.6579.86M86.51M
2018-10-310.430.4961.68M70.31M
2018-07-260.490.5567.09M75.32M
2018-04-260.270.5352.38M102.86M
2018-02-080.500.4269.52M58.38M
2017-10-250.220.3148.64M68.48M
2017-07-260.300.2758.56M52.74M
2017-04-270.180.2740.49M72.90M
2017-02-090.220.1943.61M37.65M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency Quarterly.

Safety score 43/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividend history is short. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
2015-09-08$0.252015-09-102015-09-30Quarterly
2015-06-10$0.252015-06-122015-06-30Quarterly
2015-03-10$0.252015-03-122015-03-31Quarterly
2014-11-21$0.252014-11-252014-12-23Quarterly
2014-08-26$0.252014-08-282014-09-18Quarterly

Insider trades

DateInsiderActionSharesPriceValue
2026-08-20Zhen MarianneSell1.13K$21.0023.67K
2026-08-20Basso StephenSell558$21.0011.72K
2026-08-20Raifeld PavelSell1.13K$21.0023.73K
2026-05-20Basso StephenSell559$22.2412.43K
2026-05-20Raifeld PavelSell1.13K$22.2425.13K
2026-05-20Zhen MarianneSell1.13K$22.2425.06K
2026-05-18Linden JosephineBuy9.46K——
2026-05-18Linden JosephineBuy9.17K$21.80199.82K
2026-05-18Linden JosephineBuy5.73K——
2026-05-18Linden JosephineOther0——
2026-05-15Basso StephenBuy1.12K——
2026-05-15Raifeld PavelBuy1.12K——
2026-05-04Raifeld PavelBuy312.50K$22.997.18M
2026-05-04Raifeld PavelBuy126.65K——
2026-05-04DiPaolo MarkBuy9.79K——
2026-05-04DiPaolo MarkBuy10.00K$22.99229.90K
2026-05-04Zhen MarianneBuy12.77K——
2026-05-04Zhen MarianneBuy31.50K$22.99724.18K
2026-05-04Schlesinger Sarah J.Buy9.79K——
2026-05-04Schlesinger Sarah J.Buy10.00K$22.99229.90K
2026-05-04Basso StephenBuy93.75K$22.992.16M
2026-05-04Basso StephenBuy37.99K——
2026-05-04Small Derek ABuy9.79K——
2026-05-04Small Derek ABuy10.00K$22.99229.90K
2026-05-04Haimovitz JulesBuy9.79K——
2026-05-04Haimovitz JulesBuy10.00K$22.99229.90K
2026-02-20Basso StephenSell1.24K$23.3929.10K
2026-02-20Raifeld PavelSell2.99K$23.3969.84K
2026-02-20Zhen MarianneSell2.46K$23.3957.54K
2025-11-20Basso StephenSell237$21.165.01K
2025-11-20Zhen MarianneSell992$21.1620.99K
2025-11-15Basso StephenBuy604——
2025-11-03Basso StephenBuy27.61K$18.11500.00K
2025-11-03Raifeld PavelBuy110.44K$18.112.00M
2025-08-20Basso StephenSell237$19.954.73K
2025-08-20Zhen MarianneSell991$19.9519.77K
2025-05-20Zhen MarianneSell992$18.7818.63K
2025-05-20Basso StephenSell237$18.784.45K
2025-05-19Small Derek ABuy12.08K——
2025-05-19Small Derek ABuy10.00K$18.63186.30K
2025-05-19DiPaolo MarkBuy12.08K——
2025-05-19DiPaolo MarkBuy10.00K$18.63186.30K
2025-05-19Schlesinger Sarah J.Buy12.08K——
2025-05-19Schlesinger Sarah J.Buy10.00K$18.63186.30K
2025-05-19Haimovitz JulesBuy12.08K——
2025-05-19Haimovitz JulesBuy10.00K$18.63186.30K
2025-05-15Raifeld PavelBuy1.86K——
2025-05-15Basso StephenBuy1.35K——
2025-03-14Raifeld PavelBuy243.75K$17.394.24M
2025-03-14Raifeld PavelBuy37.38K$17.39649.99K
2025-03-06DENNER ALEXANDER JSell1.20M$17.5220.96M
2025-03-05DENNER ALEXANDER JSell270.37K$17.634.77M
2025-03-04DENNER ALEXANDER JOther0——
2025-03-04DENNER ALEXANDER JSell151.18K$17.632.67M
2025-02-24Zhen MarianneBuy30.30K$18.08547.82K
2025-02-24Zhen MarianneBuy8.94K$18.08161.60K
2025-02-24Basso StephenBuy100.83K$18.081.82M
2025-02-24Basso StephenBuy10.57K$18.08191.09K
2025-02-20Zhen MarianneSell2.56K$18.0746.35K
2025-02-20Basso StephenSell1.11K$18.0719.99K
2024-11-20Zhen MarianneSell976$19.1518.69K
2024-11-15Basso StephenBuy843——
2024-11-15Zhen MarianneBuy300——
2024-08-20Zhen MarianneSell975$18.4918.03K
2024-06-17Srivastava SapnaBuy13.92K——
2024-06-17Srivastava SapnaBuy10.00K$16.16161.60K
2024-06-17Small Derek ABuy13.92K——
2024-06-17Small Derek ABuy10.00K$16.16161.60K
2024-06-17Schlesinger Sarah J.Buy13.92K——
2024-06-17Schlesinger Sarah J.Buy10.00K$16.16161.60K
2024-06-17Odysseas Kostas DBuy13.92K——
2024-06-17Odysseas Kostas DBuy10.00K$16.16161.60K
2024-06-17Haimovitz JulesBuy13.92K——
2024-06-17Haimovitz JulesBuy10.00K$16.16161.60K
2024-06-17DiPaolo MarkBuy13.92K——
2024-06-17DiPaolo MarkBuy10.00K$16.16161.60K
2024-05-20Ronsheim MatthewSell268$16.134.32K
2024-05-20Zhen MarianneSell976$16.1315.74K
2024-04-29Small Derek ASell833——
2024-04-29Small Derek ASell1.21K——
2024-03-05Basso StephenBuy25.90K$14.88385.38K
2024-03-05Basso StephenBuy12.10K$14.88179.99K
2024-03-05Ronsheim MatthewBuy27.34K$14.88406.79K
2024-03-05Ronsheim MatthewBuy12.77K$14.88189.99K
2024-03-05Zhen MarianneBuy23.02K$14.88342.57K
2024-03-05Zhen MarianneBuy10.75K$14.88159.99K
2024-03-05Raifeld PavelBuy150.00K$20.003.00M
2024-03-05Raifeld PavelBuy100.00K$18.001.80M
2024-03-05Raifeld PavelBuy75.00K$14.881.12M
2024-02-20Ronsheim MatthewSell807$15.8012.75K
2024-02-20Zhen MarianneSell2.86K$15.8045.22K
2024-01-18Ronsheim MatthewBuy60.00K$16.05963.00K
2024-01-18Ronsheim MatthewSell1.60K$16.0525.68K
2024-01-01Ronsheim MatthewSell0——
2024-01-01Ronsheim MatthewSell17.47K——
2024-01-01Ronsheim MatthewSell16.50K$12.98214.17K
2024-01-01Ronsheim MatthewSell16.60K$12.48207.17K
2023-11-20Zhen MarianneSell784$13.6210.68K
2023-11-15Zhen MarianneBuy302——
2023-11-15Zhen MarianneSell5.59K$14.0178.30K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 310, holders +23 vs prior quarter. Ownership 102.18%.

HolderSharesChangeChange %Value
BLACKROCK, INC.11.56M247.36K+2.19%262.42M
DIMENSIONAL FUND ADVISORS LP4.49M57.63K+1.30%102.06M
VANGUARD PORTFOLIO MANAGEMENT LLC4.22M-4.68K-0.11%95.84M
RENAISSANCE TECHNOLOGIES LLC4.04M-19.10K-0.47%91.67M
STATE STREET CORP3.27M207.63K+6.78%74.22M
VANGUARD CAPITAL MANAGEMENT LLC3.16M16.47K+0.52%71.72M
MILLENNIUM MANAGEMENT LLC2.54M261.66K+11.48%57.71M
GEODE CAPITAL MANAGEMENT, LLC2.07M144.99K+7.51%47.13M
SYSTEMATIC FINANCIAL MANAGEMENT LP2.02M-517-0.03%45.96M
BOSTON PARTNERS1.93M209.09K+12.16%43.78M
SARISSA CAPITAL MANAGEMENT LP1.89M-240.35K-11.28%42.94M
BANK OF AMERICA CORP /DE/1.67M47.70K+2.94%37.87M
GOLDMAN SACHS GROUP INC1.62M26.71K+1.68%36.79M
AMERICAN CENTURY COMPANIES INC1.50M-411.98K-21.57%34.02M
MARSHALL WACE, LLP1.45M-50.09K-3.33%33.03M
MORGAN STANLEY1.22M-89.92K-6.86%27.73M
ROYCE & ASSOCIATES LP1.17M111.24K+10.48%26.63M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.15M-12.41K-1.07%26.15M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.1.15M1.15MNew26.15M
TWO SIGMA INVESTMENTS, LP1.03M-451.46K-30.42%23.46M
QUBE RESEARCH & TECHNOLOGIES LTD974.12K188.02K+23.92%22.12M
DEUTSCHE BANK AG\917.96K9.89K+1.09%20.85M
NORTHERN TRUST CORP831.20K56.90K+7.35%18.88M
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN830.37K-61.96K-6.94%18.86M
INVESCO LTD.732.72K-171.56K-18.97%16.64M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Innoviva (INVA) Stock Insights

INVA$21.12+0.18 +0.86%

$1.53B

Market Cap

4.29

P/E

8.73

Forward P/E

70

Score

Price History